{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:21:25Z","timestamp":1791559285062,"version":"4.3.4"},"reference-count":20,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2017,9,12]],"date-time":"2017-09-12T00:00:00Z","timestamp":1505174400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Pharma and Therapeutics"],"published-print":{"date-parts":[[2017,10]]},"abstract":"<jats:p>\n                    There is an increasing understanding on the etiology of chronic immune\u2010mediated inflammatory diseases such as inflammatory bowel disease (IBD), psoriasis, or rheumatoid arthritis. Large consortia contributed to the elucidation of the genetics, for instance, of IBD identifying a number of genes involved in innate mucosal defense and immune tolerance (most prominent, e.g.,\n                    <jats:italic>NOD2<\/jats:italic>\n                    ) and other related processes.\n                    <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"#cpt792-bib-0001\"\/>\n                    For a number of such diseases, common genetic susceptibility loci were identified, suggesting overlapping immune response pathways, although there is no causality of single genetic traits.\n                    <jats:sup>2<\/jats:sup>\n                    In particular, the elucidation of main triggers of inflammation like tumor necrosis factor alpha (TNF\u03b1), integrins, specific cytokines like interleukin (IL)\u20106 or IL\u201023 launched the successful development of new pharmacological approaches, leading to a tremendous improvement of therapeutic outcomes.\n                  <\/jats:p>","DOI":"10.1002\/cpt.792","type":"journal-article","created":{"date-parts":[[2017,9,12]],"date-time":"2017-09-12T01:25:38Z","timestamp":1505179538000},"page":"564-567","source":"Crossref","is-referenced-by-count":16,"title":["Inflammation: Treatment Progress and Limitations"],"prefix":"10.1111","volume":"102","author":[{"given":"Ingolf","family":"Cascorbi","sequence":"first","affiliation":[{"name":"Institute of Experimental and Clinical Pharmacology University Hospital Schleswig\u2010Holstein Campus Kiel Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,9,12]]},"reference":[{"key":"e_1_2_2_1_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature10209"},{"key":"e_1_2_2_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3528"},{"key":"e_1_2_2_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.793"},{"key":"e_1_2_2_4_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-012567"},{"key":"e_1_2_2_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.791"},{"key":"e_1_2_2_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)60250-0"},{"key":"e_1_2_2_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature03727"},{"key":"e_1_2_2_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.782"},{"key":"e_1_2_2_9_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1432-1327.2001.01867.x"},{"key":"e_1_2_2_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2017.83"},{"key":"e_1_2_2_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.788"},{"key":"e_1_2_2_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.753"},{"key":"e_1_2_2_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-016-3435-2"},{"key":"e_1_2_2_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.727"},{"key":"e_1_2_2_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.747"},{"key":"e_1_2_2_16_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.01081"},{"key":"e_1_2_2_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.789"},{"key":"e_1_2_2_18_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-2291"},{"key":"e_1_2_2_19_1","doi-asserted-by":"publisher","DOI":"10.2147\/JBM.S60514"},{"key":"e_1_2_2_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.794"}],"container-title":["Clinical Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcpt.792","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cpt.792","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T08:35:43Z","timestamp":1699346143000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/10.1002\/cpt.792"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,12]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["10.1002\/cpt.792"],"URL":"https:\/\/doi.org\/10.1002\/cpt.792","archive":["Portico"],"relation":{},"ISSN":["0009-9236","1532-6535"],"issn-type":[{"value":"0009-9236","type":"print"},{"value":"1532-6535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,12]]}}}